390 related articles for article (PubMed ID: 30064166)
1. [Distant Metastasis in Patients with Non-Muscle Invasive Bladder Cancer without Local Recurrence : Report of Two Rare Cases].
Kida K; Shimizu Y; Ogawa K; Kanamaru S; Ito N
Hinyokika Kiyo; 2018 Jun; 64(6):271-275. PubMed ID: 30064166
[TBL] [Abstract][Full Text] [Related]
2. [A Case of Para-Aortic Lymph Node Metastasis 10 Years after Transurethral Resection for Non-Muscle Invasive Bladder Cancer].
Horibe Y; Ujike T; Fukuhara S; Fujita K; Kiuchi H; Uemura M; Imamura R; Nonomura N
Hinyokika Kiyo; 2021 Jul; 67(7):327-330. PubMed ID: 34353015
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes of second transurethral resection in non-muscle invasive high-grade bladder cancer: a retrospective, multi-institutional, collaborative study.
Kamiya N; Suzuki H; Suyama T; Kobayashi M; Fukasawa S; Sekita N; Mikami K; Nihei N; Naya Y; Ichikawa T
Int J Clin Oncol; 2017 Apr; 22(2):353-358. PubMed ID: 27744487
[TBL] [Abstract][Full Text] [Related]
4. Management of high-risk non-muscle invasive bladder cancer.
Brausi M; Olaru V
Minerva Urol Nefrol; 2012 Dec; 64(4):255-60. PubMed ID: 23288212
[TBL] [Abstract][Full Text] [Related]
5. [A Case of PT1 Plasmacytoid Variant Bladder Cancer Treated by Bladder Conserving Therapy].
Kimura H; Uemura Y; Megumi Y; Fukuzawa S
Hinyokika Kiyo; 2018 Sep; 64(9):369-372. PubMed ID: 30369228
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for intravesical recurrence in patients with high-grade T1 bladder cancer in the second TUR era.
Takaoka E; Matsui Y; Inoue T; Miyazaki J; Nakashima M; Kimura T; Oikawa T; Kawai K; Yoshimura K; Habuchi T; Ogawa O; Nishiyama H
Jpn J Clin Oncol; 2013 Apr; 43(4):404-9. PubMed ID: 23444116
[TBL] [Abstract][Full Text] [Related]
7. Oncological outcomes of a single but extensive transurethral resection followed by appropriate intra-vesical instillation therapy for newly diagnosed non-muscle-invasive bladder cancer.
Koie T; Ohyama C; Hosogoe S; Yamamoto H; Imai A; Hatakeyama S; Yoneyama T; Hashimoto Y; Yoneyama T; Tobisawa Y; Mori K
Int Urol Nephrol; 2015 Sep; 47(9):1509-14. PubMed ID: 26149637
[TBL] [Abstract][Full Text] [Related]
8. Significance of the interval between first and second transurethral resection on recurrence and progression rates in patients with high-risk non-muscle-invasive bladder cancer treated with maintenance intravesical Bacillus Calmette-Guérin.
Baltacı S; Bozlu M; Yıldırım A; Gökçe Mİ; Tinay İ; Aslan G; Can C; Türkeri L; Kuyumcuoğlu U; Mungan A
BJU Int; 2015 Nov; 116(5):721-6. PubMed ID: 25715815
[TBL] [Abstract][Full Text] [Related]
9. [Small cell carcinoma of the urinary bladder: a case report].
Koroku M; Tanda H; Katoh S; Onishi S; Nakajima H; Nanbu A; Nitta T; Akagashi K
Hinyokika Kiyo; 2001 Oct; 47(10):743-5. PubMed ID: 11758359
[TBL] [Abstract][Full Text] [Related]
10. Is intravesical Bacillus Calmette-Guérin therapy superior to chemotherapy for intermediate-risk non-muscle-invasive bladder cancer? An ongoing debate.
Han KS; You D; Jeong IG; Kwon T; Hong B; Hong JH; Ahn H; Ahn TY; Kim CS
J Korean Med Sci; 2015 Mar; 30(3):252-8. PubMed ID: 25729246
[TBL] [Abstract][Full Text] [Related]
11. [Occurrence of Distant Metastasis During Bladder Presevation in T1 high-grade Bladder Cancer: Report of Three Cases].
Kim CJ; Ide H; Nakamura M; Hanada E
Hinyokika Kiyo; 2023 Sep; 69(9):249-254. PubMed ID: 37794675
[TBL] [Abstract][Full Text] [Related]
12. Lymphovascular invasion in transurethral resection specimens as predictor of progression and metastasis in patients with newly diagnosed T1 bladder urothelial cancer.
Cho KS; Seo HK; Joung JY; Park WS; Ro JY; Han KS; Chung J; Lee KH
J Urol; 2009 Dec; 182(6):2625-30. PubMed ID: 19836779
[TBL] [Abstract][Full Text] [Related]
13. [A second transurethral resection could be not necessary in all high grade non-muscle-invasive bladder tumors].
Gaya JM; Palou J; Cosentino M; Patiño D; Rodríguez-Faba O; Villavicencio H
Actas Urol Esp; 2012 Oct; 36(9):539-44. PubMed ID: 22710093
[TBL] [Abstract][Full Text] [Related]
14. [Conservative treatment of locally advanced bladder carcinoma: neoadjuvant chemotherapy, TUR and radiotherapy. Results in 40 patients].
Serretta V; Vasile P; Falletta V; Piazza F; Pavone C; Pavone-Macaluso M
Arch Ital Urol Androl; 1998 Jun; 70(3 Suppl):37-40. PubMed ID: 9707769
[TBL] [Abstract][Full Text] [Related]
15. Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder.
Karam JA; Lotan Y; Ashfaq R; Sagalowsky AI; Shariat SF
Urology; 2007 Sep; 70(3):482-6. PubMed ID: 17905101
[TBL] [Abstract][Full Text] [Related]
16. [RENAL CELL CARCINOMA METASTASIS TO BLADDER DURING MOLECULAR TARGETED THERAPY WITH PAZOPANIB: REPORT OF TWO CASES].
Maruo K; Takahashi A; Tabata H; Takayanagi A; Takagi Y
Nihon Hinyokika Gakkai Zasshi; 2020; 111(2):58-61. PubMed ID: 33883361
[TBL] [Abstract][Full Text] [Related]
17. Novel nomograms to predict recurrence and progression in primary non-muscle-invasive bladder cancer: validation of predictive efficacy in comparison with European Organization of Research and Treatment of Cancer scoring system.
Kim HS; Jeong CW; Kwak C; Kim HH; Ku JH
World J Urol; 2019 Sep; 37(9):1867-1877. PubMed ID: 30535715
[TBL] [Abstract][Full Text] [Related]
18. [A CASE OF METASTATIC BLADDER UROTHELIAL CARCINOMA WHOSE DISEASE WAS CONTROLLED FOR A RELATIVE LONG PERIOD BY MULTIDISCIPLINARY TREATMENT INCLUDING RADIATION TO A LUNG METASTASIS AND MULTIPLE COURSES OF CHEMOTHERAPY].
Hamada S; Ito K; Kanbara T; Tsujita Y; Yoshii H; Tasaki S; Asakuma J; Horiguchi A; Asano T
Nihon Hinyokika Gakkai Zasshi; 2017; 108(1):35-40. PubMed ID: 29367507
[TBL] [Abstract][Full Text] [Related]
19. High-Grade T1 on Re-Transurethral Resection after Initial High-Grade T1 Confers Worse Oncological Outcomes: Results of a Multi-Institutional Study.
Ferro M; Vartolomei MD; Cantiello F; Lucarelli G; Di Stasi SM; Hurle R; Guazzoni G; Busetto GM; De Berardinis E; Damiano R; Perdonà S; Borghesi M; Schiavina R; Almeida GL; Bove P; Lima E; Grimaldi G; Autorino R; Crisan N; Abu Farhan AR; Verze P; Battaglia M; Serretta V; Russo GI; Morgia G; Musi G; de Cobelli O; Mirone V; Shariat SF
Urol Int; 2018; 101(1):7-15. PubMed ID: 29975950
[TBL] [Abstract][Full Text] [Related]
20. [DISSEMINATED CARCINOMATOSIS OF THE BONE MARROW WITH UROTHELIAL CARCINOMA].
Kohno M; Miyama K; Gohbara A; Onuki T; Sugiura S; Ikeda I
Nihon Hinyokika Gakkai Zasshi; 2015 Apr; 106(2):114-7. PubMed ID: 26415362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
